Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution

BACKGROUND: Angiosarcoma is an uncommon endothelial malignancy and a highly aggressive soft tissue sarcoma. Due to its infiltrative nature, successful management of localized angiosarcoma is often challenging. Systemic chemotherapy is used in the metastatic setting and occasionally in patients with...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Immunother Cancer
Autori principali: Florou, Vaia, Rosenberg, Andrew E., Wieder, Eric, Komanduri, Krishna V., Kolonias, Despina, Uduman, Mohamed, Castle, John C., Buell, Jennifer S., Trent, Jonathan C., Wilky, Breelyn A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6686562/
https://ncbi.nlm.nih.gov/pubmed/31395100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0689-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi